4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-19-005448
Chief Executive Officer sold 7,800 shares at an average $35.06 ($273,433)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ciechanover Isaac E. Chief Executive Officer | 2019-01-23 | Sale | −3,000 | $34.84 | $104,520 | 301,252 | I |
| Ciechanover Isaac E. Chief Executive Officer | 2019-01-23 | Sale | −800 | $35.59 | $28,472 | 300,452 | I |
| Ciechanover Isaac E. Chief Executive Officer | 2019-01-23 | Sale | −100 | $36.58 | $3,658 | 300,352 | I |
| Ciechanover Isaac E. Chief Executive Officer | 2019-01-24 | Sale | −3,470 | $34.98 | $121,381 | 296,882 | I |
| Ciechanover Isaac E. Chief Executive Officer | 2019-01-24 | Sale | −430 | $35.82 | $15,403 | 296,452 | I |
| Open-market sales · 7,800 sh · avg $35.06 · $273,433 | |||||||
Loading xslF345X03/doc4.xml…